GHRS

Conviction 80HealthcareScan · Thu, Jun 25, 2026

GHRS$25.40+3.23%

ResistanceSupportVol 14

Vol MA14 283.1K

Mar 26Apr 14May 1May 19Jun 8Jun 25

GH Research PLCBiotechnologywww.ghres.com ↗

Price25.40

Change+3.23%

Gap+0.49%

Rel volume0.59×

Avg volume274.83K

Avg $ vol6.16M

SMA 2022.39

SMA 5021.45

SMA 20016.16

Price vs 50+18.39%

Price vs 200+57.14%

MA stackbullish

50/200 cross—

Supertrendup · 20.03

RSI (14)67

MACD hist0.33

MACD crossbull · 2d

Stoch %K / %D99 / 86

ADX (14)31

+DI / −DI30 / 12

RSI divergenceBullish

MACD divergence—

ATR %+6.42%

ADR %7.62%

52w high25.40

52w low11.80

From 52w high+0.00%

Above 52w low+115.21%

New 52w highYes

SqueezeOff

Bollinger width32.06%

%B0.92

Donchian pos91.51%

Donchian high25.94

Donchian low19.52

AVWAP (52w high)22.30

vs AVWAP high+13.85%

AVWAP (52w low)16.05

vs AVWAP low+58.26%

OBV trendUp

Chaikin MF (20)-0.08

Today vs 20d0.59×

Avg vol (14d)283.1K

Avg vol (20d)274.83K

Avg $ vol (20d)6.16M

Market cap1.58B

RS 3m (vs SPY)+71.46%

RS 6m (vs SPY)+82.08%

RS line new highYes

Trend template8/8

Technical rank94.0

1 week+17.03%

1 month+9.70%

3 months+86.04%

6 months+95.05%

1 year+102.51%

YTD+91.81%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target41.67

Target upside64.09%

Analyst ratingBuy

Institutional69.39%

Ent. value1.58B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out68.61M

Employees73

ListedFri, Jun 25, 2021

Free float45.24M

Float %72.9%

Short interest2.2M

Days to cover7.5d

Short volume30.5%

Squeeze score35 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.31 · 2 est

Last EPS vs est−$0.31 vs −$0.27

Last surprise-14.8% miss

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank94.0 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance24.84

Support19.63

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in GHRS

All disclosures →

No recent disclosed trades by Congress in GHRS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GHRS

No recent insider (Form 4) filings in GHRS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GHRS · 1 recent

EDGAR →

8-K6-KThu, Jun 4, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.